CN Patent

CN116710441A — 制备2-羟基-6-((2-(1-异丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)苯甲醛的方法

Assigned to Global Blood Therapeutics Inc · Expires 2023-09-05 · 3y expired

What this patent protects

本公开涉及制备式(I)化合物的方法。

USPTO Abstract

本公开涉及制备式(I)化合物的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN116710441A
Jurisdiction
CN
Classification
—
Expires
2023-09-05
Drug substance claim
No
Drug product claim
No
Assignee
Global Blood Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.